BRIEF-Shanghai RAAS Blood Products' shares to halt trading pending announcement
BRIEF-Guizhou Xinbang Pharmaceutical receives GMP certificate
* Says co received goods manufacture practice (GMP) certificate from Guizhou Food and Drug Administration, for pills (condensed pills) manufactured by co and the valid period is until June 11, 2022